[Ectopic production of amylase by a non-producing type of multiple myeloma]. 1990

H Wada, and T Ohtsuki, and T Sugihara, and K Ata, and M Hashimoto, and O Yamada, and Y Yawata, and T Manabe, and K Miyamoto
Department of Internal Medicine, Kawasaki Medical School.

The patient was a 64-year-old woman who was admitted to our hospital because of lumbago. A diagnosis of multiple myeloma (non-producing type) was made, based on (1) the presence of multiple osteolytic lesions, (2) hypercellular marrow with 64.2% plasmacytoid malignant cells, (3) no monoclonal gamma-globulin was detected in the serum and urine, and (4) abnormal monoclonal gamma-globulin was also not detected in the cytoplasm and membranes of these malignant cells. After several courses of chemotherapy, a pleural effusion infiltrated by myeloma cells developed and the patient's serum contained a markedly increased amylase activity of salivary-type. Amylase activity was also detected in vitro in the supernatant of cultured myeloma cells established from the patient's pleural effusion. The presence of alpha-amylase in the myeloma cells, which were derived from pleural effusion, was demonstrated immuno-histochemically. These observations indicates that amylase was ectopically produced by these myeloma cells. Interestingly, 14 out of 20 metaphases in the cells derived from pleural effusion showed translocation of 1p22 near the region of 1p21, where the amylase gene was assigned.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D002878 Chromosomes, Human, Pair 1 A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification. Chromosome 1
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000681 Amylases A group of amylolytic enzymes that cleave starch, glycogen, and related alpha-1,4-glucans. (Stedman, 25th ed) EC 3.2.1.-. Diastase,Amylase
D014178 Translocation, Genetic A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome. Chromosomal Translocation,Translocation, Chromosomal,Chromosomal Translocations,Genetic Translocation,Genetic Translocations,Translocations, Chromosomal,Translocations, Genetic
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D016066 Pleural Effusion, Malignant Presence of fluid in the PLEURAL CAVITY as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells. Malignant Pleural Effusion,Effusion, Malignant Pleural,Effusions, Malignant Pleural,Malignant Pleural Effusions,Pleural Effusions, Malignant

Related Publications

H Wada, and T Ohtsuki, and T Sugihara, and K Ata, and M Hashimoto, and O Yamada, and Y Yawata, and T Manabe, and K Miyamoto
October 1988, Cancer,
H Wada, and T Ohtsuki, and T Sugihara, and K Ata, and M Hashimoto, and O Yamada, and Y Yawata, and T Manabe, and K Miyamoto
November 1992, Journal of internal medicine,
H Wada, and T Ohtsuki, and T Sugihara, and K Ata, and M Hashimoto, and O Yamada, and Y Yawata, and T Manabe, and K Miyamoto
August 1989, Blood,
H Wada, and T Ohtsuki, and T Sugihara, and K Ata, and M Hashimoto, and O Yamada, and Y Yawata, and T Manabe, and K Miyamoto
September 1991, Archives of pathology & laboratory medicine,
H Wada, and T Ohtsuki, and T Sugihara, and K Ata, and M Hashimoto, and O Yamada, and Y Yawata, and T Manabe, and K Miyamoto
June 1991, [Rinsho ketsueki] The Japanese journal of clinical hematology,
H Wada, and T Ohtsuki, and T Sugihara, and K Ata, and M Hashimoto, and O Yamada, and Y Yawata, and T Manabe, and K Miyamoto
November 2007, [Rinsho ketsueki] The Japanese journal of clinical hematology,
H Wada, and T Ohtsuki, and T Sugihara, and K Ata, and M Hashimoto, and O Yamada, and Y Yawata, and T Manabe, and K Miyamoto
January 1998, Ryoikibetsu shokogun shirizu,
H Wada, and T Ohtsuki, and T Sugihara, and K Ata, and M Hashimoto, and O Yamada, and Y Yawata, and T Manabe, and K Miyamoto
April 1978, Cancer,
H Wada, and T Ohtsuki, and T Sugihara, and K Ata, and M Hashimoto, and O Yamada, and Y Yawata, and T Manabe, and K Miyamoto
October 1977, Clinica chimica acta; international journal of clinical chemistry,
H Wada, and T Ohtsuki, and T Sugihara, and K Ata, and M Hashimoto, and O Yamada, and Y Yawata, and T Manabe, and K Miyamoto
January 1993, Acta haematologica,
Copied contents to your clipboard!